In addition, although further investigation is needed, 64Cu-DOTA-anti-CTLA-4 mAb could be used in the diagnosis of other types of tumor invaded by T cells, regardless of CTLA-4 expression in the tumor cells. This evidence concerns the gene CTLA4 and neoplasm.